This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gmbh. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Roland Grenningloh: Innovator in BTK Inhibitor Assays
Introduction
Roland Grenningloh is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of assays for BTK inhibitors. His work is essential for advancing therapeutic strategies in various diseases.
Latest Patents
Grenningloh holds a patent for "Assays for BTK inhibitors," which relates to BTK occupancy assays. This invention plays a crucial role in understanding the efficacy of BTK inhibitors in clinical applications. He has 1 patent to his name, showcasing his innovative approach to solving complex problems in the pharmaceutical industry.
Career Highlights
Currently, Grenningloh is associated with Merck Patent GmbH, where he continues to contribute to groundbreaking research and development. His expertise in the field has positioned him as a valuable asset to his organization and the broader scientific community.
Collaborations
Grenningloh has worked alongside talented colleagues, including Andrew Bender and Lesley Liu-Bujalski. Their collaborative efforts have further enhanced the research and development initiatives at Merck.
Conclusion
Roland Grenningloh's contributions to the field of BTK inhibitors exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also paves the way for future therapeutic developments.